Skip to content

Corton's effect in improving patients with covid-19

evaluation of efficacy and safety of low dose Corticosteroid with severe Pneumonia covid-19

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200611047727N3
Enrollment
60
Registered
2021-01-03
Start date
2020-07-22
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

covid _19. Coronavirus infection, unspecified

Interventions

Intervention 1: Intervention group: In the intervention group, methylprednisolone succinate was treated with 0.75-1 mg / kg and after 5 days, due to the information in the questionnaire, the disease o

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Corton's effect in improving patients with covid-19 Definitive diagnosis based on Covid-19 test result At least 7 days have passed since the onset of symptoms and at least 5 days of antiviral treatment Oxygen saturation level less than 93

Exclusion criteria

Exclusion criteria: Patients who are unable to go for follow-up scans

Design outcomes

Primary

MeasureTime frame
Radiological changes. Timepoint: Before the intervention and six weeks later. Method of measurement: Through CT scan of the lungs.

Secondary

MeasureTime frame
Oxygen levels. Timepoint: Before the intervention and six weeks later. Method of measurement: pulse oximeter.;Dyspnea. Timepoint: Before the intervention and six weeks later. Method of measurement: In this questionnaire, it is estimated based on MMRC.;Disease severity. Timepoint: Before the intervention and six weeks later. Method of measurement: Based on the amount of oxygen and clinical symptoms and CT involvement.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Mirenayat

Shahid Beheshti University of Medical Sciences

MirenayaT_M@yahoo.com+98 21 2610 5050

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026